OPTOPOL TECHNOLOGY SPÓLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA – Trademark Portfolio

Entity Type: 16

OPTOPOL TECHNOLOGY SPÓLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 2 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. The owner is based in PL-42-400 Zawiercie.

ul. Zabia 42

PL-42-400 Zawiercie , PL

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

OPTOPOL TECHNOLOGY SPÓLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (2 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does OPTOPOL TECHNOLOGY SPÓLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA have?

OPTOPOL TECHNOLOGY SPÓLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA has 2 U.S. trademarks filed with the USPTO.

What trademark classes does OPTOPOL TECHNOLOGY SPÓLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA file in?

OPTOPOL TECHNOLOGY SPÓLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What is OPTOPOL TECHNOLOGY SPÓLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA's trademark registration success rate?

OPTOPOL TECHNOLOGY SPÓLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA has a 0% trademark registration rate, with 0 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.